Hyundai Bio plans trials of antiviral for dengue fever
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
Reuters Pharma USA 2024 – Serena Goodwin
AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.
Experimental AI predicts whether cancer drugs will work
Researchers in the US have developed an artificial intelligence tool that can predict how a patient will respond to cancer treatment, bringing the concept of personalised
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, wh
FDA clears Roche’s Alecensa for adjuvant use in NSCLC
Roche has broken new ground with its ALK inhibitor Alecenesa, becoming the first drug in the class to be approved by the FDA for adjuvant use after surgery in early-stage,
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
FT US PHARMA AND BIOTECH SUMMIT
2024 is a pivotal year for the US healthcare sector.
2nd RNA Assay Development Screening Summit
This August, the 2nd RNA Assay Development & Screening Summit returns to Boston as the first and only industry dedicated event on developing sensitive, and reproducible assay and screening meth
3rd HF Drug Discovery & Development Summit
The Industry’s Only Definitive Forum for Preclinical Heart Failure Drug Development
5th Gamma Delta T Cell Therapies Summit
The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various subsets to off
PM Society Digital Awards 2024 – Open for Entries
The PM Society Digital Awards 2024 have opened for entries!